Data Monitoring Committee
Data Monitoring Committee
The Data Monitoring Committee (DMC), also known as a Data and Safety Monitoring Board (DSMB), is a group of independent experts who monitor patient safety and treatment efficacy data while a clinical trial is ongoing.
Pronunciation
- Data: /ˈdeɪtə/, /ˈdætə/, /ˈdɑːtə/
- Monitoring: /ˈmɒnɪtərɪŋ/
- Committee: /kəˈmɪti/
Etymology
The term "Data Monitoring Committee" is derived from the words "data" (facts and statistics collected together for reference or analysis), "monitoring" (observe and check the progress or quality of something over a period of time), and "committee" (a group of people appointed for a specific function by a larger group).
Definition
A Data Monitoring Committee is an independent group that is appointed to review interim safety and efficacy data in a clinical trial. The DMC has the power to recommend continuation, modification, or termination of a trial based on these interim results.
Related Terms
- Clinical trial: A research study that tests how well new medical approaches work in people.
- Interim analysis: An analysis of data from a clinical trial that occurs before the data collection has been completed.
- Independent review board: A committee that has been formally designated to approve, monitor, and review biomedical and behavioral research involving humans.
- Efficacy: The ability to produce a desired or intended result.
- Safety: The condition of being protected from or unlikely to cause danger, risk, or injury.
See Also
External links
- Medical encyclopedia article on Data Monitoring Committee
- Wikipedia's article - Data Monitoring Committee
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski